Our Mission
The essence of Ketamine Psychotherapy Associates (KPA) is its dedication to the elaboration of psychedelic psychotherapy, its ethical conduct and its expansion as standard of care practices through supporting practitioners worldwide. We are an International Membership Group focused on ketamine and its therapeutic and research elaboration as the only legally available psychedelic medicine.
Our broad approach to methodology is enabling of both present and future provision of care as other alternative medicines are approved for prescription, or decriminalized as is occurring in various localities. Benefits to members are broadly supportive of developing and existing practices.
We welcome your application.
The improved KPA
In the interest of improving attendance, increasing membership, and our benefits to members, we are initiating changes and additions that are aimed at accomplishing these goals.
- We are moving our every two weeks consultation/supervision/sharing meeting to Wednesdays at 9-10:30 am Pacific/12-1:30pm East
- New Annual Fee Structure:
– $500 for MDs, DOs
– $400 for FNPs, NPs, and other prescribers in this category
– $300 for therapists
– $1,000 for a clinic group of 3-4
– $1,500 for a clinic group of 5 or more
Those who have paid in the last year the $1000 fee will be credited for an additional year of membership. - Annual renewals will be automatic based on first month of membership
- Scheduled Annual Advanced Training.
- CEs on a monthly meeting basis for 18 credits—proof or attendance or viewing of recording.
- Continuation of: referral info on our site; eligibility for Access to Care; Redcap for data and record keeping; discount for personal consultations.
— Phil Wolfson, Peter Corbett, the participants in the Advanced Sharing, and the Board of KRF/KPA
More About KPA
Ketamine Psychotherapy Associates (KPA) is a part of The Ketamine Research Foundation (KRF), and as such shares in its non-profit status. While having its own cost center status and bank account, KPA participates in KRF under its tax identification number. The Board of KRF also provides direction for KPA.
In concert with the Ketamine Research Foundation (KRF), the Associates organization pursues data collection and assessment through Vanderbilt University’s Redcap protocol—our Ketamine Data Project (KDP). We request affiliates join us in this effort to know and grow our understanding of ketamine therapies. As KRF’s finances grow, so too does its support for indigent patient’s seeking financial assistance for Ketamine Assisted Psychotherapy (KAP) through application by therapist members of KPA.